At a glance
ClinicalIndex Comparison RecordN/ACompleted· 306 enrolled
Drug / intervention
doxycycline +2 moredrug
Likely dose
doxycycline 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Duration of Antibiotic Treatment of Erythema Migrans. A Randomized Clinical Trial.
In Brief
A clinical study evaluating doxycycline and placebo for Erythema Chronicum Migrans. Completed, enrolled 306 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the efficacy of 15-day versus 10-day doxycycline treatment in patients with erythema migrans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErythema Chronicum Migrans
CountriesSlovenia
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Enrollment StartJun 2009
Primary CompletionNov 2010
TodayJul 2026
First PostedJun 1, 2009
Enrollment StartJun 1, 2009
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 17.1 years ago
Interventions
doxycyclinedrug
doxycycline 100 mg bid, 10 days
doxycyclinedrug
doxycycline 100 mg bid, 15 days
placebodrug
control subjects without a history of Lyme borreliosis